EUVIMEDEUVIMED entdecken
Crossref

Standardized Reporting of HCC with LI-RADS and mRECIST: Update on the Situation in Germany

Christian Nelles, Inka Ristow iD, Markus S Juchems, Johannes Wessling, Kristina Imeen Ringe iD, Ana Fehrmann-Efferoth iD, Simon Lennartz, Saif Afat, Ahmed Othman, Michel Eisenblätter, Roman Paul, Mirjam Gerwing und 1 weitere

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.09.2025 · 197 (09) · 1043-1056

DOI: 10.1055/a-2438-1670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.09.2025. Verfasst von Christian Nelles und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Ger…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tomography, X-Ray Computed. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Online survey about the current status of CT protocols in hepatocellular carcinoma (HCC) in the year 2023/2024. Moreover, the usage of structured reporting using LI-RADS and mRECIST was surveyed and the results were compared with a survey from 2020. Radiologists working in outpatient or inpatient care in Germany were invited. The survey was conducted between 10/2022 and 06/2023 and between 06/2024 and 08/2024. HCC-related questions were asked regarding the commonly used imaging modalities, body coverage, and contrast phases in CT, as well as the usage of structured assessment and treatment response using mRECIST and LI-RADS. More than half of the participants stated that they “frequently” perform imaging of HCC. In the CT protocol, acquisition of a pre-contrast phase was widespread. While a late arterial and a portal venous contrast phase was acquired in most cases, a delayed phase was used much less frequently (at small and medium-sized hospitals only in 26.5%). For staging, LI-RADS was used in structured reports in only 13%; for response monitoring mRECIST was used at university hospitals in only 26.5% and LI-RADS in 14.7%, whereas these have been almost never used in routine practice at all other sites. The main reasons given for the lack of application were the expenditure of time, the lack of reporting templates, problems with integration into the IT infrastructure and a lack of reimbursement. The recommendation of a three phase CT examination in late arterial, portal venous, and delayed phase for HCC diagnostics according to LI-RADS is only partially implemented in Germany. Structured reporting for staging and response monitoring using LI-RADS and mRECIST was at a similarly low level in Germany in 2023 compared to 2020. Possible solutions include the development and distribution of online educational resources, structured reporting templates, and inexpensive IT solutions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTomography, X-Ray ComputedHumansGermanyNeoplasm StagingSurveys and QuestionnairesRadiology Information Systems

Autor:innen und Institutionen

  • Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany.
  • Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Diagnostic and Interventional Radiology, Klinikum Konstanz, Konstanz, Germany.
  • Department of Radiology, Clemenshospital GmbH Munster, Munster, Germany.
  • Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
  • Department of Diagnostic and Interventional Radiology, Eberhard Karls University Tübingen Faculty of Medicine, Tubingen, Germany.

ORCID-Profile: Inka Ristow, Kristina Imeen Ringe, Ana Fehrmann-Efferoth, Thorsten Persigehl

Zitieren

APA

Nelles, C., Ristow, I., Juchems, M. S., Wessling, J., Ringe, K. I., Fehrmann-Efferoth, A., Lennartz, S., Afat, S., Othman, A., Eisenblätter, M., Paul, R., Gerwing, M., & Persigehl, T. (2025). Standardized Reporting of HCC with LI-RADS and mRECIST: Update on the Situation in Germany. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 197(09), 1043-1056. https://doi.org/10.1055/a-2438-1670

Vancouver

Nelles C, Ristow I, Juchems MS, Wessling J, Ringe KI, Fehrmann-Efferoth A, et al. Standardized Reporting of HCC with LI-RADS and mRECIST: Update on the Situation in Germany. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2025;197(09):1043-1056. doi:10.1055/a-2438-1670

BibTeX
@article{Nelles2025,
  author = {Nelles, Christian and Ristow, Inka and Juchems, Markus S and Wessling, Johannes and Ringe, Kristina Imeen and Fehrmann-Efferoth, Ana and Lennartz, Simon and Afat, Saif and Othman, Ahmed and Eisenblätter, Michel and Paul, Roman and Gerwing, Mirjam and Persigehl, Thorsten},
  title = {Standardized Reporting of HCC with LI-RADS and mRECIST: Update on the Situation in Germany},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year = {2025},
  volume = {197},
  number = {09},
  pages = {1043--1056},
  doi = {10.1055/a-2438-1670}
}
Kostenlos starten →